Impact of hydroxyurea on perioperative management and outcomes in children with sickle cell anemia

Masanori Hayashi1, Agustin Calatroni, Brittany Herzberg

  • 1Department of Pediatrics, Division of Hematology/Oncology, Duke University Medical Center, Durham, NC, USA.

Insights

Children with sickle cell anemia on hydroxyurea require fewer perioperative transfusions. This study found hydroxyurea use significantly reduced transfusion needs in pediatric patients undergoing surgery, with low complication rates.

Area of Science:

  • Pediatric Hematology
  • Surgical Management
  • Sickle Cell Disease Treatment

Background:

  • Sickle cell anemia (HbSS genotype) presents significant challenges in pediatric surgical care.
  • Hydroxyurea is an established treatment that modifies disease severity in sickle cell anemia.
  • Perioperative management, including blood transfusions, is critical for patients with sickle cell anemia.

Purpose of the Study:

  • To compare perioperative transfusion requirements and outcomes in children with sickle cell anemia who were taking hydroxyurea versus those not taking it.
  • To evaluate the impact of hydroxyurea on transfusion strategies in the perioperative period for pediatric patients with sickle cell disease.

Main Methods:

  • Retrospective review of 51 children with sickle cell anemia (HbSS genotype) undergoing surgery between January 2003 and April 2008.
  • Comparison of perioperative transfusion management (no transfusion, single transfusion, serial transfusions/pheresis) between patients on hydroxyurea and those not on hydroxyurea.
  • Analysis of complication rates, including transfusion reactions and acute chest syndrome.

Main Results:

  • Children taking hydroxyurea (n=30) received significantly fewer perioperative transfusions compared to those not taking hydroxyurea (n=21) (P=0.004).
  • Only 27% of hydroxyurea patients required no preoperative transfusion, compared to 5% in the non-hydroxyurea group.
  • While complication rates were low in both groups, one patient not on hydroxyurea experienced a delayed hyperhemolytic transfusion reaction.

Conclusions:

  • Hydroxyurea therapy is associated with a substantial reduction in perioperative transfusions for children with sickle cell anemia undergoing surgery.
  • Both hydroxyurea and non-hydroxyurea groups demonstrated low overall complication rates.
  • Further research is warranted to optimize perioperative protocols for pediatric sickle cell anemia patients receiving hydroxyurea.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
334
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
550
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
376
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
442
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.2K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.2K